Zeynep Ağırman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Zeynep Ağırman has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Can Acipayam
Department of Pediatrics, Pediatric Hematology‐Oncology Faculty of Medicine Kahramanmaraş Sütçü İmam University Kahramanmaraş Turkey
1 shared publication - Fatih Temiz
KAHRAMANMARAŞ SÜTÇÜ İMAM ÜNİVERSİTESİ, TIP FAKÜLTESİ
1 shared publication Nurten Akkececi
Department of Physiology, Faculty of Medicine Kahramanmaras Sutcu Imam University Kahramanmaras Turkey
1 shared publication
Latest Publications
- 12 December 2024
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 61 (2) , 237-240
Evaluation of endocrine changes and insulin release in patients with hereditary spherocytosis
Aim: To evaluate endocrinological changes and insulin secretion in patients with hereditary spherocytosis (HS).Methods: The study included 30 patients with HS and 30 healthy control groups who were of similar age and gender. Routine tests, including hemogram, biochemical and hormonal tests were conducted on both patients with HS and the control group. HOMA‐IR (Homeostasis Model Assessment for Insulin Resistance) and HOMA‐ß% (Homeostasis Model Assessment for ß‐cell function) values of all cases were also calculated using fasting insulin and fasting glucose values.Results: Among the patient group, 7 patients (23.3%) had short stature, 16 patients (53.3%) had vitamin D deficiency, 1 patient (3.3%) had impaired glucose tolerance, 1 patient (3.3%) had subclinical hypothyroidism, 23 patients (76.6%) had dyslipidemia and 2 patients (6.6%) had growth hormone deficiency. The insulin value in the patient group was 4.0 ± 2.7 mlU/mL and significantly lower than the control group with an insulin value of 9.1 ± 3.9 mlU/mL (P < 0.001). Moreover, glucose (P = 0.036), HOMA‐IR (P < 0.001), HOMA‐beta (P < 0.001) and C‐peptide (P = 0.001) values of the patient group were significantly lower than the control group. The cholesterol (P < 0.001), HDL (P < 0.001) and LDL (P < 0.001) values of the patient group were found to be significantly lower than the control group.Conclusion: We found that insulin secretion decreased in patients with HS and hypocholesterolemia occurred due to chronic hemolysis. More research is needed to elucidate the pathophysiology of decreased insulin secretion seen in HS patients.
- 12 December 2024
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 61 (2) , 237-240
Evaluation of endocrine changes and insulin release in patients with hereditary spherocytosis
Aim: To evaluate endocrinological changes and insulin secretion in patients with hereditary spherocytosis (HS).Methods: The study included 30 patients with HS and 30 healthy control groups who were of similar age and gender. Routine tests, including hemogram, biochemical and hormonal tests were conducted on both patients with HS and the control group. HOMA‐IR (Homeostasis Model Assessment for Insulin Resistance) and HOMA‐ß% (Homeostasis Model Assessment for ß‐cell function) values of all cases were also calculated using fasting insulin and fasting glucose values.Results: Among the patient group, 7 patients (23.3%) had short stature, 16 patients (53.3%) had vitamin D deficiency, 1 patient (3.3%) had impaired glucose tolerance, 1 patient (3.3%) had subclinical hypothyroidism, 23 patients (76.6%) had dyslipidemia and 2 patients (6.6%) had growth hormone deficiency. The insulin value in the patient group was 4.0 ± 2.7 mlU/mL and significantly lower than the control group with an insulin value of 9.1 ± 3.9 mlU/mL (P < 0.001). Moreover, glucose (P = 0.036), HOMA‐IR (P < 0.001), HOMA‐beta (P < 0.001) and C‐peptide (P = 0.001) values of the patient group were significantly lower than the control group. The cholesterol (P < 0.001), HDL (P < 0.001) and LDL (P < 0.001) values of the patient group were found to be significantly lower than the control group.Conclusion: We found that insulin secretion decreased in patients with HS and hypocholesterolemia occurred due to chronic hemolysis. More research is needed to elucidate the pathophysiology of decreased insulin secretion seen in HS patients.